Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS to Improve Cognition in Parkinson's

NCT: NCT03836950 · RECRUITING

NCT IDNCT03836950
StatusRECRUITING
Start Date2020-04-01
Completion2028-03-30

Brief Summary

The purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinking. The hypothesis is that rTMS can improve thinking for people with Parkinson's disease or atypical parkinsonism who are experiencing mild problems with their thinking ability.

Frequently Asked Questions

What is rTMS to Improve Cognition in Parkinson's?

rTMS to Improve Cognition in Parkinson's is a clinical trial registered under NCT03836950. Current status: RECRUITING.

What is the status of NCT03836950?

The current status of NCT03836950 (rTMS to Improve Cognition in Parkinson's) is: RECRUITING.

When did rTMS to Improve Cognition in Parkinson's start?

rTMS to Improve Cognition in Parkinson's started on 2020-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑